Treatment of Recurring Lower Leg Cellulitis
First-Line Management
For patients with recurring lower leg cellulitis, prophylactic low-dose penicillin (250 mg twice daily) is recommended for 12 months to prevent recurrence, particularly in patients without predisposing factors. 1
The management of recurring lower leg cellulitis involves both treating acute episodes and implementing preventive strategies:
Acute Episode Treatment
First-line antibiotic therapy:
Alternative options:
MRSA consideration:
- Add MRSA coverage (trimethoprim-sulfamethoxazole 1-2 DS tablets twice daily) if patient has:
- Previous MRSA infection/colonization
- Injection drug use
- Failed initial antibiotic treatment
- Immunocompromised status 2
- Add MRSA coverage (trimethoprim-sulfamethoxazole 1-2 DS tablets twice daily) if patient has:
Prevention of Recurrence
Antibiotic Prophylaxis
Penicillin V 250 mg twice daily for 12 months is the preferred prophylactic regimen 1, 3
Alternative prophylaxis:
- Monthly intramuscular benzathine penicillin G injections may be considered, particularly effective in patients without predisposing factors 4
Managing Risk Factors
Addressing underlying risk factors is crucial for long-term prevention:
- Treat lymphedema with compression therapy
- Manage venous insufficiency
- Treat fungal infections (tinea pedis, onychomycosis)
- Control edema in patients with heart failure
- Optimize glycemic control in diabetic patients
- Address obesity through weight management 3, 5, 6
Monitoring and Follow-up
- Evaluate response to treatment within 48-72 hours of initiating antibiotics 2
- If no improvement after 72 hours:
Special Considerations
Patients with predisposing factors:
Common pitfalls to avoid:
- Failing to distinguish between cellulitis and pseudocellulitis
- Unnecessary MRSA coverage in low-prevalence areas
- Excessive treatment duration
- Not elevating the affected limb
- Overlooking underlying predisposing factors 2
The evidence strongly supports prophylactic antibiotics for recurring cellulitis, with penicillin V showing the most robust evidence in recent high-quality studies. However, management of underlying risk factors remains essential for long-term prevention of recurrences.